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phenotype mimicking pleomorphic malignant
fibrous histiocytoma: a case report
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and Antonio Llombart-Bosch4Abstract: Primary sarcomas of the major blood vessels can be classified based on location in relationship to the
wall or by histologic type. Angiosarcomas are malignant neoplasms that arise from the endothelial lining of the
blood vessels; those arising in the intimal compartment of pulmonary artery are rare. We report a case of
pulmonary artery angiosarcoma in a 36-year old female with pulmonary masses. The patient had no other primary
malignant neoplasm, thus excluding a metastatic lesion. Gross examination revealed a thickened right pulmonary
artery and a necrotic and hemorrhagic tumor, filling and occluding the vascular lumen. The mass extended distally,
within the pulmonary vasculature of the right lung. Microscopically, an intravascular undifferentiated tumor was
identified. The tumor cells showed expression for vascular markers VEGFR, VEGFR3, PDGFRa, FGF, Ulex europaeus,
FVIII, FLI-1, CD31 and CD34; p53 was overexpressed and Ki67 proliferative rate was increased. Intravascular
angiosarcomas are aggressive neoplasms, often associated with poor outcome.
Virtual slide: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
2315906377648045.
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Primary sarcomas of the major blood vessels can be clas-
sified based on location in relationship to the wall
(mural or intraluminal (also known as “intimal”) or by
histologic type. Angiosarcomas are malignant tumors
that arise from the endothelial lining of the blood vessels
[1]. Pulmonary artery sarcomas (PAS) include two types:
intimal sarcomas, presenting as intraluminal growing
excrescences, and mural sarcomas, involving the pul-
monary artery wall. PAS are rare tumors, with unknown
and probably, underestimated incidence, which may
show myofibroblastic, leiomyosarcomatous, osteosarco-
matous, rhabdomyosarcomatous or angiosarcomatous
differentiation [2]. Angiosarcoma of the pulmonary artery
is a distinctive tumor and few cases have been reported
to the date [2,3].* Correspondence: olga.bohn@gmail.com
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A 36-year-old female presented to the clinic with a
3-month history of non-productive cough and weight loss.
Her past medical history was unremarkable. Chest X-rays
and a computed tomography (CT) scan showed two right
perihilar lung masses, each measuring 3.5 and 2.5 cm in
greater diameter, adjacent to the main right pulmonary ar-
tery (Figure 1). No extrapulmonary masses were identified
by PET scan and CT; therefore, metastatic disease was
excluded. A bronchoscopy was performed and transbron-
chial biopsies were taken but were non diagnostic. She
had a thoracoscopic exploration and an open-lung biopsy.
A pathology report showed a malignant fibrous histiocy-
toma (MFH) of the lung. A right pneumonectomy was
performed and she required 2 days in the ICU; pulmonary
artery hypertension and tachycardia developed, which
resolved with digoxin and diltiazem.Pathological findings
The specimen consisted of a total right lung, weighing
994 grams and measuring 35 × 11 × 7 cm. On thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Pulmonary artery angiosarcoma. A and B. CT-chest shows two circumscribed pulmonary masses.
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abut pleural surfaces were identified. Cut sections
showed a right pulmonary artery thickening and a nec-
rotic and hemorrhagic tumor, filling and near occluding
the vascular lumen (Figure 2). The mass extended dis-
tally, within the pulmonary vasculature of the right lung.
The smaller arterial branches were thickened. In
addition, the lung parenchyma showed two lobulated
and circumscribed yellow-tan masses with necrosis,
hemorrhage and myxoid appearance, measuring 3.5 ×
3.2 × 3 cm and 2.5 × 2 × 2 cm. The bronchial and vascu-
lar margins of resection were free of tumor.
Microscopic examination showed an intravascular
undifferentiated tumor composed of loosely cohesive
large, pleomorphic spindle and epithelioid cells with
prominent nucleoli, admixed with multinucleated giant
cells (Figure 3). Numerous mitotic figures were seen.
Interestingly, the pleomorphic tumor cells were found
arising from the intima of the vessels, extending and occu-
pying the vascular lumen. Medium sized vessels showed
intraluminal tumor. Masson’s trichrome was useful toFigure 2 Pulmonary artery angiosarcoma. A. Tumor abutting the pleura
and near total right pulmonary occlusion.identify vessels components and the origin of tumor cells
(not shown). The lung parenchyma also revealed a tumor
similar that presented in pulmonary vessel, with solid,
myxoid and hemangiopericytoid growth patterns. The
original biopsy slides were reviewed, and the findings
were identical to those identified within the vascular
spaces and lung parenchyma. The original biopsy diagno-
sis was MFH pleomorphic variant.
A broad panel of immunohistochemical markers was
used as shown in Table 1. The tumor cells showed
strong positivity for Vimentin, FGF, PDGFRa, Factor
VIII, Ulex europaeus, FLI1, CD31 and CD34; VE-cad-
herin, VEFGR and VEGFR3 were focal positive in epithe-
lioid tumor cells; there was p53 overexpression (25%)
and Ki67 proliferative rate ranged from 10 to 40%
(Figure 4). Tumor cells lacked expression for AE1AE3,
EMA, CK 8/18, HMB45, Melan A, desmin, h-Caldesmon,
SMA and S100.
Based on clinical, radiological and histopathological
findings, the tumor was diagnosed as angiosarcoma
arising on the pulmonary artery.l surface. B. Right pneumonectomy showing intraparenchymal masses
Figure 3 Pulmonary artery angiosarcoma. A, B. Endovascular tumor with intimal component (HE 40X, 10X). C, D. Intravascular angioblastic
proliferation (HE 200X, 400X). E. Malignant tumor cells with vacuoles (HE 400X). F. Large epithelioid malignant tumor cells (HE 400X).
G. Angioblasts within malignant vascular neoformation (HE 200X). H. Atypical endothelial proliferation (HE 400X).
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The patient received four cycles of ifosfamide-based
chemotherapy with tolerable toxicity. Eighteen months
after diagnosis an extensive radiological examination
showed no other primary neoplasm or metastatic lesion.
The patient was disease free 18 months and then thetumor recurred (additional biopsies were taken showing
similar histopathological findings). She developed meta-
static disease to liver and contralateral lung and died 29
months after the recurrence. No autopsy was performed.
Primary sarcomas arising from major blood vessels
(aorta, pulmonary artery, inferior vena cava) are
Table 1 List of antibodies
ANTIBODY CLONE SOURCE DILUTION
VIMENTIN Monoclonal mouse V9 Novocastra 1:300
CD31 Monoclonal mouse anti-h JC70A DAKO 1:100
CD34 Monoclonal mouse QBEnd/10 Novocastra 1:100
VE-CADHERIN Goat polyclonal Santa cruz Biotechnology 1:100
VEGF Mouse monoclonal VG1 Neomarkers 1:100
VEGFR3 Rabbit polyclonal Santa cruz Biotechnology 1:400
PDGFRa Rabbit polyclonal Santa cruz Biotechnology 1:100
FGF-2 Rabbit polyclonal Santa cruz Biotechnology 1:200
Factor VIII Rabbit polyclonal DAKO 1:200
ULEX EUROPAEUS-I LECTIN Rabbit polyclonal Sigma 1:500
FLI-1 Monoclonal mouse MRQ1 Cell Marque 1:100
EMA Monoclonal mouse E29 DAKO 1:100
CK 8/18 Monoclonal mouse 5D3 Novocastra 1:50
CK AE1-AE3 Monoclonal mouse AE1-AE3 DAKO 1:100
S100 Rabbit polyclonal DAKO 1:600
HMB45 HMB45 DAKO 1:100
Melan A A103 DAKO 1:50
Desmin DE-R11 DAKO 1:100
h-Caldesmon Monoclonal mouse h-CD DAKO 1:50
Ki67 Monoclonal mouse MIB-1 DAKO 1:200
P53 Monoclonal mouse DO-7 Novocastra 1:50
VE indicates vascular endothelial; VEGF, vascular endothelial growth factor; PDGFRa, platelet-derived growth factor receptor alpha; FGF, fibroblast growth factor;
EMA, epithelial membrane antigen; CK, cytokeratin.
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in the literature have been autopsy reports [5,9,10]. Most
patients are adults, however, a few cases have been
found in children [11]. Burke et al. [5] found that in-
timal sarcomas affect males more frequently than
females and arise predominatly in the right pulmonary
vessels, with intraluminal involvement rather than intra-
parenchymal infiltration.
Clinically, primary sarcomas of the major blood vessels,
are usually associated to embolic phenomena [6,12,13];
therefore, their true incidence is probably underesti-
mated because of misdiagnosis with thromboembolism,
especially when located at aorta [11]. The radiographic
distinction of pulmonary thromboembolic disease and
pulmonary artery sarcoma (PAS) is challenging, because
both conditions appear as intraluminal filling defects in
the pulmonary artery system on contrast-enhanced CT
scans [14,15]. Some authors have reported that the diag-
nosis may be suspected by magnetic resonance imaging
(MRI) [4,6] and positron emission tomography (PET)
[15]. However, findings that favor a diagnosis of a PAS
include the heterogeneous soft tissue density and the
enhancement of the gadolinium contrast [11,16].
Therefore, PAS should always be considered as a pos-
sibility, as a misdiagnosis with thromboembolic diseasewill result in delaying appropriate therapy and increased
morbi-mortality [15,17].
Grossly, a careful examination of the specimen, the
pulmonary vasculature and its branches is essential to
achieve the correct diagnosis. PAS may spread and grow
as intraluminal masses along the endothelium and an
organizing thromboemboli needs to be ruled out [18].
In addition, direct lung parenchyma involvement is a
common event, as direct extension through the pul-
monary vasculature can occur due to the prominent
intravascular growth along the arterial intima. On the
other hand, mural sarcomas with a solid growth can
also be confused with other entities including meta-
static extension from primary malignancies of the lung
or tumors from the mediastinum, such as lymphoma
and sarcomas [19]. In our case, an extensive work-up
that included clinical and radiological evaluation was a
key determinant for the appropriate conclusion of the
case.
Pulmonary artery sarcomas of the lung are malignant
tumors of indeterminate cause, usually presenting
heterogenous histology that most likely reflect a pluripo-
tential or mesenchymal cell origin [20]. Some examples
that have been reviewed in the literature represent undif-
ferentiated sarcomas that may display a myofibroblastic
Figure 4 Pulmonary artery angiosarcoma. A. CD31 expression in tumor cells. B. CD34 highlights tumor cells. C. Strong positivity for Factor VIII.
D. FLI-1 shows nuclear expression. E. Ulex europaeus positive staining. F. FGF expression. G. Ki67 nuclear staining. H. p53 nuclear staining.
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osteosarcomatous, chondrosarcomatous, rhabdomyosar-
comatous, liposarcomatous and angiosarcomatous ele-
ments have also been described [5,6,8-10,21-23]. The
present case displays an undifferentiated sarcoma that
mimics pleomorphic malignant fibrous histiocytoma;however, the tumor expresses the majority of vascular-
specific markers. It is important to highlight that the final
diagnosis could not have been achieved without a high
level of suspicion. Interestingly, one of the most signifi-
cant features helpful for identification of angiosarcoma
was the intimal origin of the tumor. Furthermore,
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comas have been confused with malignant neoplasms
(primary or metastatic malignancies) with dedifferen-
tiated component, such as carcinomas, sarcomas and
lymphomas [24-27]. Differential diagnoses in this specific
case include high grade sarcomas with leiomyosarcoma-
tous, fibro or myofibroblastic differentiation. For that
reason, an appropriate and consecutive utilization of a
broad panel of antibodies, and occasionally, electron mi-
croscopy (not used in this case) are often necessary to
distinguish the origin [8,13,28]. We found in this case,
that co-expression of endothelial markers such as VEGF,
PDGFR, Ulex europaeus, FLI1, CD31 and CD34 is useful
in classifying the neoplasm, representing an unusual
presentation of a true angiosarcoma similar to those
observed in soft tissues.
Although in this case it was not possible to identify
specific exposure, angiosarcomas have been reported
associated to previous irradiation fields [29] or arterio-
venous fistulas [30]. Comparative genomic hybridization
(CGH) analysis of intimal pulmonary sarcomas have
shown gains and amplifications in the 12q13–14 region,
with other less consistent findings including losses on
3p, 3q, 4q, 9p, 11q, 13q, Xp, and Xq, gains on 7p, 17p,
and 17q, and amplifications on 4q, 5p, 6p, and 11q [18].
Currently, no prognostic markers have been extensively
studied; however, in one study, Gaumann et al. [31]
found that osteopontin expression may contribute to
metastasis due to its role in cell attachment and there-
fore to poor prognosis. In addition, Bode-Lesniewska
et al. [18] reported that dysregulation of the cell cycle
proteins in p53 pathway and overexpression of mdm2
might be implicated in the pathogenesis. At this point,
further gene profiling studies, including a larger group
of this specific type of vascular malignancy can be used
to identify predictive and prognostic markers for intra-
vascular angiosarcoma of the pulmonary vessels.
Overall, PAS are considered aggressive neoplasms,
often associated to poor outcome irrespective of treat-
ment [9,10,32,33], and with no exception for pulmonary
artery angiosarcomas. Only few patients have survived
more than 12 months [5,34]; surgery and complete re-
section of the tumor provide local control. Adjuvant
chemotherapy and radiotherapy have a controversial role
in the management of this disease [5,33]. The role of
chemotherapy is unclear, but a 50% response rate has
been found to palliative chemotherapy with anthracy-
clines and ifosfamide in patients with advanced PAS
[11,35].
Conclusion
In summary, we report an unusual case of pulmonary
artery sarcoma with angiosarcoma phenotype that
mimics pleomorphic malignant fibrous histiocytoma. Ahigh level of suspicion and identification of the intimal
location of the tumor, in addition to the use of a broad
panel of immunohistochemical markers were helpful
for the identification of the vascular origin. A multidis-
ciplinary clinical and radiological approach and an exten-
sive work-up were key determinant for the appropriate
conclusion of the case.
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